Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

"There’s people walking around that obviously do not have blonde hair – yet they do. I don’t think that’s weird either. It’s ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Obesity is spreading in the United States, as 75% of of adults and almost half of people aged 15-24 are overweight.

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

Lower Manhattan-based Metsera is one of the latest drug startups to throw its hat into the ring with the pharma giants ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Four out of five men and women in the United States will be overweight or obese by 2050 if current trends hold, a new study ...